-
Recent Posts
- Dementia-Friendly Communities Provision, Viewed as a Social Determinant of Health (JGCR / NHS England / WHO)
- International Perspectives on the Possible Impact of the COVID-19 Pandemic and Lockdown on Abuse of the Elderly (JGCR / American Journal of Geriatric Psychiatry / JAGS)
- Updates Relating to the Lancet Commission on Dementia Prevention, Intervention, and Care (Lancet / Alzheimer’s Research and Therapy / Alzheimer’s and Dementia)
- A Brief Review of How the COVID-19 Pandemic Relates to Elderly Care and Research (JGCR)
- Some Speculated / Potential Benefits of COVID-19 (JGCR / BBC Radio 4’s Rethink / BGS)
Archives
- September 2020
- August 2020
- June 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: JAMA Neurology
Vitamin E and / or Selenium for Dementia Prevention? (JAMA Neurology)
Summary The Prevention of Alzheimer’s Disease by Vitamin E and Selenium (PREADViSE) trial investigated the potential use of antioxidant supplementation (whether Vitamin E and / or selenium) for the prevention of dementia in asymptomatic older men. This study has now … Continue reading
Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Non-Pharmacological Treatments, Nutrition, Pharmacological Treatments
Tagged Alpha-Tocopherol (Vitamin E), Alzheimer's Disease Center: University of Kentucky, Antioxidant Supplements, Antioxidants, College of Medicine: University of Kentucky, Dementia Risk Reduction and Prevention, Department of Biostatistics: University of Kentucky, Department of Chemistry: University of Kentucky, Department of Epidemiology: University of Kentucky, Department of Neurology: University of Kentucky, Dietary Supplements, Fred Hutchinson Cancer Research Center (Seattle), Futility Analyses, JAMA Neurology, Micronutrient Supplementation, Nutritional Supplementation, Nutritional Supplements, Oral Nutritional Supplements (ONS), Oxidative Stress, Prevention, Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADViSE) Trial, Prevention of Alzheimer's Disease by Vitamin E and Selenium Trial (PREADViSE), Prevention of Dementia, Sanders-Brown Center on Aging: University of Kentucky, Selenium, Selenium and Vitamin E Cancer Prevention Trial (SELECT), SWOG Statistical Center: Fred Hutchinson Cancer Research Center, United States, University of Kentucky, USA, Vitamin E
Leave a comment
Proton Pump Inhibitors Increase the Risk of Dementia? (NHS Choices / JAMA Neurology)
Summary One of NHS Choices, Behind the Headlines‘ “Top News Stories of 2016”. It appears that people using proton pump inhibitors (PPIs) may have a 44% higher risk of developing dementia over a seven-year period. “This finding is supported by … Continue reading
Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Pharmacological Treatments, Quick Insights, Statistics, Universal Interest
Tagged Allgemeine Ortskrankenkassen (AOK), Behind the Headlines, Dementia Risk Factors, Dementia Risk Reduction and Prevention, Department of Psychiatry: University of Bonn, Epidemiology, Epidemiology and Statistics, Esomeprazole, Federal Institute for Drugs and Medical Devices (Germany), German Center for Neurodegenerative Diseases, Germany, Indigestion Drugs (PPIs) and Dementia, Institute for Sociology and Demography: University of Rostock, JAMA Neurology, Lansoprazole, Max-Planck-Institute for Demographic Research (Germany), Modifiable Risk Factors, Omeprazole, Pantoprazole, Proton Pump Inhibitors (PPIs), Public Awareness of the Risk Factors for Dementia (2016 UK), Rabeprazole, Risk Factors, Rostock Center for the Study of Demographic Change, University of Bonn, University of Rostock
Leave a comment
Unexpected Antisocial Behaviour / Criminality: a Potential Indicator of Frontotemporal Dementia? (JAMA Neurology / BBC News / NHS Choices)
Summary The authors of this article investigated criminal behavior among patients diagnosed with Frontotemporal Dementia and Alzheimer Disease to understand how these disorders can result differentially in antisocial and criminal behaviour. A retrospective medical record review of 2397 patients covered … Continue reading
Posted in Alzheimer’s Research UK, BBC News, Charitable Bodies, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, International, Mental Health, Models of Dementia Care, Quick Insights, Universal Interest
Tagged Antisocial Behaviour in Alzheimer Disease, Antisocial Behaviour in Frontotemporal Dementia, Australia, BBC Radio 4, BBC Radio 4: Today Programme, Behavioural and Psychological Symptoms of Dementia (BPSD), Behavioural Frontotemporal Dementia (bvFTD), Behavioural Variant Frontotemporal Dementia (bvFTD), BPSD: Behavioral and Psychological Symptoms of Dementia, Consortium for Frontotemporal Dementia Research, Criminal Behaviour in Alzheimer Disease, Criminal Behaviour in Frontotemporal Dementia, Criminality, Department of Medicine: University of Notre Dame, Department of Neurology: University of California, Diminished Responsibility, Disinihibition, Division of Oncology and Pathology: Lund University, Dr Laura Phipps: Alzheimer’s Research UK, Drink Driving, Driving Under the Influence, Emotional Blunting, Fronto-Temporal Dementia (FTD), Frontotemporal Dementia, Hennerlöfska Foundation for Medical Research, Hillblom Aging Network (US), Hit and Run, Huntington Disease, Huntington’s Disease, Impaired Emotional Processing, Impaired Executive Function, Impaired Judgment, Impaired Self-Awareness, Inappropriate Sexual Advances, Inappropriate Sexual Behaviour, Insanity Defense (American Legal System), Insubordination Towards Legal Authorities, JAMA Neurology, Lack of Inhibition, Loitering / Stalking, Lund University (Sweden), Memory and Aging Center: University of California, Mental Health and the Criminal Justice System, National Institutes of Health (NIH), Out-of-Character Criminal Behaviour, Out-of-Character Irresponsibility, Out-of-Character Racism, Out-of-Character Sexism, Out-of-Character Violence, Public Urination, Semantic Variant Primary Progressive Aphasia, Sexual Behavior, Sexuality and Dementia, Speeding, Sweden, Swedish Society of Medicine, Tau Consortium, Theft, Traffic Violations, Trespassing, Trolle-Wachtmeister Foundation for Medical Research (Sweden), Unexpected Antisocial Behaviour / Criminality, United States, University of California, University of Notre Dame (Australia), Unrestrained Base Impulsivity, USA, Verbal Threats, Verbal Threats of Violence, Violence, Violence and Aggression
Leave a comment
DDT (Pesticide): Potential Link with Alzheimer’s Disease (BBC News / JAMA Neurology)
Summary Exposure to the pesticide DDT, which was used commonly after WW2, may increase the risk of developing Alzheimer’s Disease, according to research published in JAMA Neurology. Patients with Alzheimer’s Disease, statistically, had four times more residual DDT lingering in … Continue reading
Posted in BBC News, For Doctors (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Quick Insights, Statistics, Universal Interest
Tagged Amyloid Precursor Protein (APP), Apolipoprotein E, Apolipoprotein E (APOE) e4 Allele, Apolipoprotein E (APOE) Gene, BBC Health News, Behind the Headlines, Critical Appraisals, DDE, DDT (Pesticide), Department of Environmental and Occupational Medicine: Rutgers Robert Wood Johnson Medical School, Department of Neurology and Alzheimer's Disease: Emory University School of Medicine, Department of Pathology: Emory University School of Medicine, Department of Psychiatry: University of Texas Southwestern Medical Center, Dichlorodiphenyldichloroethylene (DDE), Dichlorodiphenyltrichloroethane (DDT), Elevated Serum Pesticide Levels, Emory University, Environmental and Lifestyle Factors, Environmental and Occupational Health Sciences Institute: Rutgers University, Epidemiology, Epidemiology and Statistics, JAMA Neurology, Pesticides, Pesticides and Dementia, Risk Factors, Risk Factors for Alzheimer's Diseease, Rutgers University, Serum Pesticide Levels
Leave a comment